头孢菌素联合鱼腥草注射液治疗老年慢性支气管炎的效果研究

目的：观察头孢菌素联合鱼腥草注射液治疗老年慢性支气管炎的临床疗效及安全性。方法：按照随机原则将76 例老年慢性 支气管炎患者分成两组,在常规治疗的基础上,其中对照组76 人采用头孢菌素治疗,治疗组患者在对照组治疗的基础上给予鱼 腥草注射液治疗,对两组临床费用、住院时间和临床疗效进行评价。结果：治疗组和对照组的住院时间分别为(26.0± 4.2)d 和 (32.4± 3.4)d,住院时间差异有显著性(P<0.05);治疗组的医疗费用为(10477± 1273.2)元,对照组医疗费用为(12790± 892.3)元,两组 医疗费用差异有显著性(P<0.05);治疗组临床有效率为83.4%,显著高于对照组的临床有效率(70.8%)(P<0.05)。结论：头孢菌素联 合鱼腥草注射液治疗老年慢性支气管炎的临床疗效确切,值得临床推广。     

Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells

Cancer is the second leading cause of deaths worldwide. Despite concerted efforts to improve the current therapies, the prognosis of cancer remains dismal. Highly selective or specific blocking of only one of the signaling pathways has been associated with limited or sporadic responses. Using targeted agents to inhibit multiple signaling pathways has emerged as a new paradigm for anticancer treatment. Icariside II, a flavonol glycoside, is one of the major components of Traditional Chinese Medicine Herba epimedii and possesses multiple biological and pharmacological properties including anti-inflammatory, anti-osteoporosis, anti-oxidant, anti-aging, and anticancer activities. Recently, the anticancer activity of Icariside II has been extensively investigated. Here, in this review, our aim is to give our perspective on the current status of Icariside II, and discuss its natural sources, anticancer activity, molecular targets and the mechanisms of action with specific emphasis on apoptosis pathways which may help the further design and conduct of preclinical and clinical trials.Icariside II has been found to induce apoptosis in various human cancer cell lines of different origin by targeting multiple signaling pathways including STAT3, PI3K/AKT, MAPK/ERK, COX-2/PGE2 and β-Catenin which are frequently deregulated in cancers, suggesting that this collective activity rather than just a single effect may play an important role in developing Icariside II into a potential lead compound for anticancer therapy. This review suggests that Icariside II provides a novel opportunity for treatment of cancers, but additional investigations and clinical trials are still required to fully understand the mechanism of therapeutic effects to further validate it in anti-tumor therapy.     

肉苁蓉研究进展

本文就肉苁蓉资源分布、化学成分、分离提纯、药理作用和资源开发利用作一综述,并展望其发展前景     

金线莲挥发油化学成分的研究

采用水蒸气蒸馏法提取花叶开唇兰挥发油,用GC毛细管柱进行分析,归一化法测定其相对含量,并用GC-MS法鉴定化学成分。检出182个成分,鉴定出73个化合物,占挥发油总量的92.64%,主要成分为:正十六烷酸(25.22%)、(Z,Z)-9,12-十八碳二烯酸甲酯(6.47%)、11,14,17-二十碳三烯酸甲酯(4.42%)、(Z,Z)-9,12-十八碳二烯酸(15.35%)和(Z,Z,Z)-9,12,15-十八碳三烯酸甲酯(13.64%)。     

荆芥体外抗阴道毛滴虫作用机制的实验研究

目的探讨荆芥体外杀灭阴道毛滴虫的作用机制。方法将浓度为1∶4的荆芥水提液作用于体外培养的阴道毛滴虫,并采用透射电镜观察经药物作用2 h和4 h后阴道毛滴虫的超微结构变化。结果荆芥作用后阴道毛滴虫多聚核糖体解聚,粗面内质网脱颗粒,胞质内可见大量空泡;随药物作用时间延长,核膜不完整,核质变疏松;最终,胞膜破损,内容物外溢,虫体死亡。结论荆芥可破坏阴道毛滴虫的内膜系统,具有较强的抗滴虫作用。     

连钱草药材的高效毛细管电泳指纹图谱研究

建立了不同产地连钱草药材的高效毛细管电泳(HPCE)指纹图谱,并进行了比较。连钱草药材采用体积分数75%乙醇蒸馏提取;采用毛细管区带电泳法制定指纹图谱,电泳条件如下:未涂层融熔石英毛细管50μm I.D.×375μm O.D.(总长62 cm,有效长度53.5 cm),电泳缓冲液为含体积分数15%乙腈的50 mmol.L-1硼酸缓冲液(pH9.2),检测波长278 nm,操作电压25 kV,柱温25℃;以对乙酰氨基酚为参照物,建立了连钱草药材的数据化指纹图谱(相对迁移时间和相对峰面积)。结果表明:5种连钱草药材(4个产地和对照药材)具有16个共有指纹峰,不同产地连钱草药材指纹图谱的峰重叠率都低于60.3%,共有峰相对峰面积及8强峰均差异较大;连钱草药材的主要化学成分种类和质量分数均因产地不同而有差异;HPCE指纹图谱法具有较好的稳定性、精密度和重现性,简便,快速,可作为连钱草药材的质量控制方法。     

地锦粗提物对脾虚小鼠脏器指数和抗氧化能力的影响

目的探讨地锦粗提物对脾虚小鼠脏器指数和抗氧化能力的影响,为防治脾虚提供参考。方法 30只昆明小鼠随机分成3组,每组10只,即对照组、脾虚组和地锦组。脾虚组和地锦组采用泻下加劳倦方法,灌服大承气汤30 g/(kg.d),并负重游泳,对照组灌服生理盐水30 g/(kg.d),不游泳,持续60 d,然后灌胃60 d,地锦组灌胃地锦水醇浸出液30 g/(kg.d),脾虚组和对照组给予相当剂量的生理盐水。实验结束后取心、肝、脾、肺、肾,称重并计算脏器指数,测血浆过氧化氢酶(CAT)和谷胱甘肽过氧化物酶(GSH-Px)活力,测心、肝、脾、肺、肾中超氧化物歧化酶(SOD)活性和丙二醛(MDA)含量。结果脾虚组心指数和肺指数极显著增加,左肾指数显著增加,地锦组心指数显著增加。地锦组的血浆CAT和GSH-Px活力显著高于脾虚组,地锦组肝和脾中的SOD活力显著高于脾虚组,地锦组脾、肺MDA含量显著低于脾虚组。结论地锦粗提物可降低脾虚小鼠的脏器指数,并可提高脾虚小鼠抗氧化能力。     

淫羊藿提取物的抗炎作用及其机制

淫羊藿是一种常用的传统中药。黄酮类成分是淫羊藿的主要有效成分,其中淫羊藿苷是含量最高的单体成分,淫羊藿素是淫羊藿苷的代谢产物。最近十余年来,学者对淫羊藿提取物的药理作用进行了许多研究,表明淫羊藿黄酮,尤其是淫羊藿苷及其衍生物,在骨质疏松症、骨关节炎、神经和精神疾病、动脉粥样硬化、哮喘和肺部疾病、炎症性肠病、肾脏疾病、皮肤病、自身免疫性疾病和癌症等多个与慢性炎症有关的疾病模型中显示了良好的抗炎作用。淫羊藿苷及其衍生物发挥抗炎作用的分子机制主要包括降低炎症细胞因子释放和NF-κB信号通路激活,抑制NLRP3/caspase-1/IL-1β、STAT和MAPK介导的信号传导通路,上调Nrf2/ARE/HO-1信号通路以及糖皮质激素受体和雌激素受体下游信号通路等。本文综述了该领域的近期研究进展,提示淫羊藿及其所含的活性化合物具有治疗多种慢性炎症相关疾病的潜力。     

Fourteen microsatellite loci for the Chinese medicinal plant Epimedium sagittatum and cross-species application in other medicinal species

Epimedium sagittatum is a well-known medicinal plant as well as potential ground cover and ornamental plant. A total of 14 polymorphic microsatellite markers were developed for use in taxonomy, phylogenetics and conservation genetics. Markers were presented between two and eight alleles per locus. The observed heterozygosity (H(O) ) and expected heterozygosity (H(E) ) ranged from 0.03 to 0.81 and from 0.05 to 0.81, respectively. Cross-amplification among other four medicinal species revealed promising results in three to six polymorphic loci. These microsatellite loci contributed to the limited number of useful markers currently available for E. sagittatum.